Anhui Medical University

Institution (Education)

Homepage Wikipedia ROR

Also Known As

Anhui Medical University, Ānhuī Yīkē Dàxué, 安徽医科大学

55.6K

Publications

3.1M

Citations

5.5K

Authors

2.2K

Concepts

About

Anhui Medical University is a education institution in Hefei, China known for medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	87	2.3K	100.7K
2	Health Sciences	73	2.8K	115.1K
3	Education	30	305	14K
4	Business	16	99	4.2K
5	Arts	9	23	1.4K

Anhui Medical University

55.6K

Publications

3.1M

Citations

Page 1

	Year	Citations
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen, The Lancet Oncology HepatologyMedicineCancer ManagementPhase IiiClinical Trials	2008	5.8K
Epidemiology of COVID-19 Among Children in China Yuanyuan Dong, Xi Mo, Yabin Hu, PEDIATRICS	2020	4.3K
Ambient Particulate Air Pollution and Daily Mortality in 652 Cities Cong Liu, Renjie Chen, Francesco Sera, New England Journal of Medicine	2019	1.6K
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study Yongze Li, Di Teng, Xiaoguang Shi, BMJ	2020	1.6K
GOSemSim: an R package for measuring semantic similarity among GO terms and gene products Guangchuang Yu, Fei Li, Yide Qin, Bioinformatics	2010	1.4K
The burden of heat-related mortality attributable to recent human-induced climate change Ana M. Vicedo‐Cabrera, Noah Scovronick, Francesco Sera, Nature Climate Change Heat-related Mortality AttributableClimate ImpactEngineeringEnvironmental HealthClimate Change Vulnerability	2021	1.2K
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 Yong Gao, Tuantuan Li, Mingfeng Han, Journal of Medical Virology	2020	1.1K
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity Qing Zhang, Jiacheng Bi, Xiaodong Zheng, Nature Immunology Cancer ImmunosurveillanceImmunologyTumor ImmunityImmunologic MechanismImmune Checkpoint Inhibitor	2018	1.1K
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study Zhenggang Ren, Jianming Xu, Yuxian Bai, The Lancet Oncology HepatologyBevacizumab BiosimilarMedicinePathologyVersus Sorafenib	2021	1K
Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major Shanshan Hu, Cameron Marshall, Jocelyn M. Darby, Frontiers in Immunology	2018	980

Page 1